RaQualia Pharma Inc. (TYO:4579)
Japan · Delayed Price · Currency is JPY 501.00
+7.00 (1.42%)
Aug 6, 2026, 11:30 AM JST
RaQualia Pharma Market Cap
RaQualia Pharma has a market cap or net worth of 12.86 billion as of August 5, 2026. Its market cap has decreased by -1.66% in one year.
Market Cap
12.86B
Enterprise Value
11.15B
Revenue
3.82B
Ranking
n/a
PE Ratio
233.89
Stock Price
501.00
ChartMarket Cap Chart
Since July 20, 2011, RaQualia Pharma's market cap has decreased from 19.90B to 12.86B, a decrease of -35.38%. That is a compound annual growth rate of -2.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 12.86B | -47.94% |
| Dec 30, 2025 | 24.70B | 194.57% |
| Dec 30, 2024 | 8.39B | -43.62% |
| Dec 29, 2023 | 14.87B | -42.44% |
| Dec 30, 2022 | 25.84B | 5.05% |
| Dec 30, 2021 | 24.60B | 17.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AnGes | 19.54B |
| StemRIM | 18.93B |
| CanBas | 14.12B |
| ReproCELL | 12.54B |
| SUSMED,Inc. | 11.94B |
| Stella Pharma | 11.35B |
| Kubota Pharmaceutical Holdings | 9.04B |
| Immuno-Biological Laboratories | 8.94B |